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ABSTRACT 
Objective: The aim of this study was to investigate the effects of changing in the proportions of the solid dispersion formula on the dissolution rate 
of glibenclamide.  
Methods: Solid dispersions were prepared by solvent evaporation method by using methanol as solvent, hydroxypropyl methylcellulose (HPMC) 
and polyvinyl pyrrolidone (PVP) as polymers. The prepared product was evaluated by the saturated solubility test and the dissolution rate test. The 
prepared product was characterized by Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), and powder X-ray 
diffraction (PXRD) and Scanning Electron Microscopy (SEM).  
Results: The result showed solid dispersion with a ratio of glibenclamide: PVP: HPMC (1: 3: 6) has the highest increase in solubility (20 fold) 
compared to pure glibenclamide. This formula also showed an improvement in dissolution rate from 19.9±1.19% (pure glibenclamide) to 
99±1.60% in 60 min. Characterization of FT-IR showed that no chemical reaction occurred in solid dispersion of glibenclamide. The results of X-
ray diffraction analysis showed an amorphous form in all solid dispersion formulas. The results of DSC analysis showed that endothermic peak 
melting point of solid dispersion occurred, and the morphology of solid dispersion was more irregular than pure glibenclamide based on SEM 
characterization 
Conclusion: The solid dispersion of glibenclamide using PVP: HPMC as carriers can increase the solubility and dissolution rate compared to pure 
glibenclamide.  
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open-access article under the CC BY license (





Solubility is an important parameter of the absorption process of a drug. 
The poor water solubility of drug can exhibit poor bio-availability in the 
drug absorption [2]. 
One of the most widely used drug routes of administration is the oral 
route. The oral route has several advantages, including ease of 
administration, patient compliance, cost-effective and flexible 
dosage settings. However, the challenge in developing drugs with 
oral routes is their bioavailability, because many factors can affect 
bioavailability include permeability, solubility, dissolution rate and 
first pass metabolism [1].  
Based on the BCS system, there are around 40% of 
drug drugs that have been marketed that have low solubility, which can 
cause poor dissolved in the GI fluids. One of a drug that belongs to class 
II, according to BCS is glibenclamide (has high permeability, but low 
solubility). The solubility of glibenclamide in water is equal to 4 mg/l [3]. 
The low solubility of glibenclamide in water causes a low ability of 
glibenclamide to reach the systemic circulation and results in poor 
bioavailability of the drug.  The bioavailability of glibenclamide is known 
at 40-45% after oral dosing [4]. Therefore, increasing the solubility and 
dissolution of glibenclamide is important to improve the efficiency of 
administration of glibenclamide in oral preparations [5].  
Several techniques can be used to increase the solubility and 
dissolution of the drug such as complexation, the salts formation,  
particle size reduction, cocrystallization and solid dispersion [1].  
Solid dispersion applications have widely been used to improve the 
solubility and oral bioavailability of the drug [6]. Kaur and Kumar 
reported that the solid dispersion technique was able to increase 
glibenclamide solubility from 78.85±0.001 µg/ml to 260.00±0.006 
µg/ml and increased the dissolution rate from 22.41% to 93.98% 
within 60 min. Some advantages of solid dispersion techniques are 
simple, do not require a lot of equipment and can increase 
dissolution rates [7] 
In this study, glibenclamide solid dispersion was prepared using PVP 
K30 and HPMC as a polymer by solvent evaporation method in 
different ratios. 
MATERIALS AND METHODS 
Sangeetha et al. reported that using HPMC as a solid 
dispersion polymer can increase the solubility of drug 10 fold 
compared with pure drugs, while for PVP K30 can increase 2.5 fold. 
Dissolution rate at 5 min using HPMC as polymer was 98%, PVP 
66.3% and pure drug 57% [8]. PVP and HPMC also can inhibit the 
crystallization of the drug from an amorphous state during the 
solvent removal process [9].  
Materials 
Glibenclamide (PT. Indofarma Tbk), HPMC, PVP (Nanhang Industrial 
Co LTD), methanol, potassium hydrogen phosphate, potassium 
dihydrogen phosphate, Sodium Hydroxide (all reagents are 
analytical grade).  
Methods 
Preparation of solid dispersion 
Determination of drug content 
Solid dispersion of glibenclamide was prepared by mixing 
Glibenclamide and carriers according to the formula in table 1. 
Glibenclamide, HPMC and PVP K30 were dissolved in methanol and 
mixed using a magnetic stirrer until homogeneous solution. The 
mixture solution was evaporated at a temperature of 50-60 °C for 24 
h to obtain a dried sample [10]. 
Solid dispersion of glibenclamide equivalent to 50 mg of 
glibenclamide was weighed and dissolved in methanol. The solution 
was filtered through a 0.45 μm membrane filter, and the amount of 
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Table 1: Binary and ternary solid dispersion formula of glibenclamide 
Formula Glibenclamide (%) PVP (%) HPMC (%) 
F1 10 90  
F2 20 80   
F3 30 70   
F4 40 60   
F5 50 50   
F6 60 40   
F7 70 30   
F8 80 20   
F9 90 10   
F10 10   90 
F11 20   80 
F12 30   70 
F13 40   60 
F14 50   50 
F15 60   40 
F16 70   30 
F17 80   20 
F18 90   10 
F19 10 30 60 
F20 20 20 60 




Solid dispersion of glibenclamide equivalent to 10 mg of glibenclamide 
was weighed and placed into Erlenmeyer flask that contained water. 
The samples were agitated using a mechanical agitator for 24 h and 48 
h at room temperature. The saturated solutions were filtered through 
a 0.45 μm membrane filter, and the amount of the drug dissolved was 
analyzed spectrophotometrically at 300 nm [12, 13]. 
Dissolution test 
Solid dispersions equivalent to 20 mg of glibenclamide were put into 
900 ml of pH 8 phosphate buffer solution with a paddle speed of 75 
rpm. 5 ml of samples were taken at intervals of 5, 10, 15, 20, 30, 45, 60 
min. Each sample taken was replaced with 5 ml of dissolution medium. 
The dissolution samples were filtered through a syringe filter of 0.45 
μm pore size and analyzed spectrophotometrically at 300 nm [12, 13]. 
Characterization of solid dispersion 
Powder X-ray diffraction (PXRD) 
Crystal structures were analyzed by PXRD (Phillips PW1835® 
diffractometer) with the following conditions: target/filter 
(monochromator) Cu, voltage 40 kV and a tube current 30 mA. Data 
was collected by scanning mode 0.2 °-0.5 ° per minute with scanning 
distances of 2θ = 5 °-60 ° [14]. 
Differential scanning calorimetry (DSC) 
Thermal analysis of solid dispersion was conducted using DSC. A 
thermograph was recorded under a nitrogen gas flow at a flow rate 
of 50 ml/min. Samples were evaluated from 30 to 300 °C with a 
heating rate of 10 °C/min
Fourier transform infrared (FTIR) 
 [15]. 
The infrared spectrum of the samples was recorded using an 
infrared spectrophotometer using the KBr pellet. The infrared 
spectrum was recorded at 4000-400 cm-1
Scanning electron microscope (SEM) 
 wavenumbers [16]. 
Data analysis 
Sample powders were placed on the sample holder aluminum (each 
formula and pure glibenclamide) coated with gold. The sample was 
analyzed by SEM (JSM6510, JEOL) with voltage acceleration 
obtained at 15kV [15, 17]. 
Analysis of solubility and dissolution test data were presented 
RESULTS AND DISCUSSION 
as a 
mean of samples±standard deviation (SD) and were analyzed using 
the one-way analysis of variance (ANOVA) at the level of (P<0.05) 
[18].  
Preparation of solid dispersion 
Solid dispersion was prepared using the solvent evaporation 
method. In this method, the drug and polymer were dissolved in an 
organic solvent and evaporated to obtain dried sample [19]. 
Through this process, the drug will be dispersed molecularly in the 
polymer matrix [20]. PVP is a hydrophilic polymer commonly used 
as carriers for solid dispersions to increase solubility and dissolution 
of poorly water-soluble drug [11, 21]. HPMC is a water-soluble 
polymer that can be used as carriers for solid dispersion. Many 
drugs have been successfully prepared for solid dispersion using 
HPMC as a carrier. HPMC in particular cellulose can adsorb 
hydrophobic drug surfaces by the presence of 
  
methoxyl or 
hydroxypropyl groups [20, 22]. 
Content determination 
Table 2: Result of content determination of glibenclamide solid dispersion 
No Formula Average content SD 
1 F1 94.32 0.019% 
2 F5 98.42 0.008% 
3 F9 96.70 0.013% 
4 F10 93.02 0.017% 
5 F14 96.31 0.010% 
6 F18 94.44 0.020% 
7 F19 90.00 0.020% 
8 F20 95.48 0.017% 
9 F21 95.75 0.020% 
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The result of the solubility study of glibenclamide solid dispersion 






Fig. 1: The result of solubility study of glibenclamide solid 
dispersion (a) after 24 h and (b) after 48 h (All the values were 
calculated as mean±standard deviation) (n=3) 
The result showed that all solid dispersion formulas increase the 
solubility of glibenclamide compared with pure glibenclamide. The 
highest increase in solubility was in Formula 19 (GLB: HPMC: PVP 
(1:6:3) with a saturated solubility of 9.23±0.012 µg/ml compared to 
the solubility of pure glibenclamide of 0.44±0.006 µg/ml. The 
increase in solubility of this solid dispersion can be caused by the 
molecular dispersion of the drug in the hydrophilic polymer so that 
the wettability of the drug will increase. The presence of HPMC and 
PVP can form the intermolecular hydrogen bonding with 
glibenclamide [11]. The result of the solubility study was analyzed 
statistically and showed that the solubility of all solid dispersion 
formula were significant differences (ρ<0.05) 
Dissolution test 
compared with pure 
glibenclamide.  
The dissolution test results of pure glibenclamide were 
19.9±1.19% in 60 min. The highest dissolution result was 
formula 19 (99±1.60%). Based on these results, it is known that 
there was an increase in the dissolution rate of glibenclamide 
solid dispersion compared to pure drugs. The mechanism of 
solid dispersion for the improvement of dissolution rate of the 
drug are particle size reduction of drug, formation of an 
amorphous state and improved wettability. Based on the results, 
HPMC and PVP can form an amorphous state with intermolecular 
hydrogen bond, inhibit crystallization of drug and enhance 
wettability [22, 8]. 
In a ternary solid dispersion system with a mixture of PVP and 
HPMC polymers there is a combination of a mechanism for 
increasing dissolution rates of active substances. PVP has 
properties that can increase dissolution of the drug, whereas  
HPMC will produce high dispersion with high porosity having a 
synergistic effect that will increase dissolution rates compared 
with the use of single polymers. Ohyagi et al. reported that a 
synergistic effect was obtained from a combination of HPMC and 
eudragit which can increase the griseofulvin dissolution rate [15]. 
The result of the dissolution study was analyzed statistically and 
showed that the dissolution of the solid dispersion formula were 
significant differences (ρ<0.05) 
  
compared with pure 
glibenclamide. 
 
Fig. 2: The result of the dissolution study of glibenclamide solid dispersion (All the values were calculated as mean±standard deviation) (n=3) 
 
Powder X-Ray diffractometer (PXRD) 
The pure glibenclamide showed diffractogram peak with the highest 
intensity at an angle of 2Ɵ = 10.7 °, 12.3 °, 19.5 °, 19.8 °, 20.9 °, 22.1 ° 
which indicates that glibenclamide is in the crystalline state. 
Whereas for F1 solid dispersions containing 10% glibenclamide and 
90% PVP, there is halo pattern diffractogram but still found the peak 
at 2Ɵ = 10.5 °, 11.3 °, 19.7 °, 20.8 °, 21.7 ° and 22.2 °, but the intensity 
was relatively lower compared to the intensity of the peak on a pure 
glibenclamide diffractogram. In the F10 solid dispersion containing 
10% glibenclamide and 90% HPMC, there was also a halo pattern 
diffractogram with less peak observed, with relatively lower 
intensity compared to pure glibenclamide, the highest intensity 
obtained at an angle of 2Ɵ = 19.6 °, 20.1 °, 31.7 ° and 45.4 °. While the 
ternary solid dispersion formula does not appear diffractogram peak 
characteristic of glibenclamide. It is indicated that the molecular 
state of glibenclamide in ternary solid dispersion was in an 
amorphous state [23]. Any changes in diffractogram peak 
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characteristic of glibenclamide, when formulated into a solid 
dispersion, indicated that the molecular state of the drug already 
changed from crystalline state to amorphous state. Changes in 
crystallinity of glibenclamide could be one of the mechanisms 




Fig. 3: PXRD result of glibenclamide (a), F1 (b), F10 (c), F19 (d), HPMC (e), PVP (f) 
 
Differential scanning calorimetry (DSC) 
In the thermogram of DSC, the endothermic peak of pure 
glibenclamide was on 176.6 °C, indicating its crystalline nature. The 
thermal behavior of the PVP and HPMC are amorphous substances, 
with a large endothermal effect in the 60-100 °C range due to 
polymer dehydration [11]. No endothermic peaks corresponding to 
glibenclamide were observed in solid dispersions prepared by the 
solvent evaporation method. This is assumed that HPMC and PVP in 
solid dispersion can inhibit the crystallization of glibenclamide 
through hydrogen bonding between polymers with glibenclamide 
[22].  
 
According to gracin et al., the solubility of a compound or material 
has a correlation with its thermodynamic properties, the 
thermodynamic properties can be either the melting or enthalpy of 
the substance [24]. In relation to solubility, enthalpy shows changes 
in the relative energy needed to break the bonds between solute 
molecules so that the smaller enthalpy energy needed to break down 
the solute bonds becomes lower and solubility becomes higher [25]. 
 
Fig. 4: DSC thermogram of glibenclamide (blue line), PVP (gray line), HPMC (green line), F1 (red line), F10 (purple line) and F19 (brown 
line) 
 
Fourier transform infrared (FTIR) 
The FTIR spectra of pure glibenclamide showed a peak at wave 
number 3413 cm-1 ((NH stretch), 3116-1 (OH stretch), 2390-1 (CH 
stretch), 1712-1 (C = O stretch) 16121 (C = C stretch and 1350-1 
(CH) amines according to the characteristics of the 
glibenclamide structure. The PVP polymer shows a peak at wave 
number 1655-1 caused by the presence of carbonyl groups, 2955-
1 due to CH stretch and at 3450-1 (OH) which indicates the 
presence of moisture due to the hygroscopic nature of PVP. The 
HPMC FTIR spectra show that the wide peaks at wavenumber 
3470-1 show OH stretch, this is consistent with the research 
conducted [26]. 
Whereas for the solid dispersion of F1, there are still peaks at 3439-1 
(OH stretch), 2961-1 (CH stretch), 1651-1 (CO stretch) and CN at 
wave number 1299-1. For solid dispersion F10, a cluster is still 
found. The OH function at wave number 3480-1, CH at 2975-1, C = C 
at 1628-1 and CN at 13501. For F19 solid dispersions, an OH 
functional group was found stretching at 3452-1, CH at 2972-1, C = C 
at 1650-1 and amine (CN) in 12971
  
. This indicates that no chemical 
reaction occurred in the solid dispersion of glibenclamide. 
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Fig. 5: FTIR spectrum of glibenclamide (purple line), PVP (blue line), HPMC (green line), F1 (black line), F10 (gray line) and F19 (brown line) 
 
Scanning electron microscopy (SEM) 
Morphology of pure glibenclamide, HPMC, PVP, and solid dispersion 
of glibenclamide can be seen in fig. 6. The morphology of solid 
dispersion did not show a characteristic of glibenclamide crystal. It 
is assumed that glibenclamide was dispersed in HPMC and PVP. 
 
The 
irregular shape of the solid dispersion is related to the wettability of 
a solid form, although the average solid dispersion particles have a 
larger size but irregular shapes can increase the wettability of the 













Fig. 6: SEM electromicrophotograph of (a) glibenclamide, (b) Solid dispersion of F1, (c) F10, (d) F19, (e)HPMC, (f) PVP 
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The solid dispersion of glibenclamide using PVP: HPMC as carriers can 
increase the solubility and dissolution rate compared to pure 
glibenclamide. Solid dispersion with a ratio of glibenclamide: PVP: 
HPMC (1: 3: 6) has the highest increase in solubility (20 fold) 
compared to pure glibenclamide. This formula also showed an 
improvement in dissolution rate from 19.9±1.19% (pure 
glibenclamide) to 99±1.60% in 60 min. Characterization of FT-IR 
showed that no chemical reaction occurred in solid dispersions of 
glibenclamide. 
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